Choosing Wisely for genitourinary cancers

Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource-constrained settings

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

WCLC 2025: Latest in EGFR positive NSCLC

Transforming cancer care in India: The Access Cancer Care Initiative

The hidden biology of addiction and cancer

Key insights from lung cancer research at ASCO 2025

Understanding Ghana's FDA and pharmacovigilance regulations

Cost comparison of IV vs subcutaneous trastuzumab in HER2+ breast cancer in Morocco

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

Making immune check point inhibitors for lung cancer cost-effective in LMICs